Who founded Enveda Therapeutics, Inc.?

Enveda Therapeutics, Inc. was founded by Viswa Colluru in 2019.

Who are Enveda Therapeutics, Inc.'s investors?

Enveda Therapeutics, Inc.'s investors include Dimension Capital.

How much funding has Enveda Therapeutics, Inc. raised?

Enveda Therapeutics, Inc. has disclosed $67.5M raised across 2 of its 3 known rounds.

Where is Enveda Therapeutics, Inc. headquartered?

Enveda Therapeutics, Inc. is headquartered in Boulder, US.

Enveda Therapeutics, Inc.

Boulder, US · Founded 2019 · 1 known investors

Find your way into Enveda Therapeutics, Inc.

42 people in our graph share verified history with the Enveda Therapeutics, Inc. team — schools, employers, funds. One of them is your warm intro.

John Demeterunlockedknows Viswa Colluru, PhD · together at Harvard Business School Online (overlapped)

×5knows the team · via Harvard Business School Online

×2knows the team · via Recursion Pharmaceuticals

×2knows the team · via Enveda

×2knows the team · via Andhra University

Biotech

Founders & leadership

Enveda Therapeutics, Inc. was founded in 2019 by Viswa Colluru.

Viswa Colluru inFounderFounder at Enveda

Daniel WeeExecutive

Board

Rohit SharmaBoard director

Zavain DarBoard director

Bruce BeutelBoard director

Shaquille VaydaBoard director

Investors · 1

Dimension CapitalreportedSan Francisco · $1M – $10M

Reported raises · per SEC filings

Form D private placements

$67.5M disclosed across 2 of 3 rounds · 2020–2025

▶$62.5MraisedMar 2023 · 26 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Rohit SharmaDirector
Zavain DarDirector
Bruce BeutelDirector
Daniel WeeExecutive Officer
Shaquille VaydaDirector
Viswa ColluruExecutive Officer, Director

Offering amount: $62.5M
Amount sold: $62.5M
First sale: Aug 2022
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5MraisedAug 2020 · 10 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Viswa ColluruExecutive Officer, Director
Rohit SharmaDirector

Offering amount: $5M
Amount sold: $5M
First sale: Aug 2020
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Enveda Therapeutics, Inc. announced that it has received $155.660018 million in funding from a group of investors | MarketScreener Indiain.marketscreener.com · Feb 2025

Enveda Therapeutics, Inc. amended terms of the transaction -November 20, 2024 | MarketScreenermarketscreener.com · Nov 2024

Frequently asked questions

Who founded Enveda Therapeutics, Inc.?: Enveda Therapeutics, Inc. was founded by Viswa Colluru in 2019.
Who are Enveda Therapeutics, Inc.'s investors?: Enveda Therapeutics, Inc.'s investors include Dimension Capital.
How much funding has Enveda Therapeutics, Inc. raised?: Enveda Therapeutics, Inc. has disclosed $67.5M raised across 2 of its 3 known rounds.
Where is Enveda Therapeutics, Inc. headquartered?: Enveda Therapeutics, Inc. is headquartered in Boulder, US.